- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Proliferative Diabetic Retinopathy in Ireland
Total 454 results
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Canada, Mexico, Guatemala, Germany, Brazil, Puerto Rico, Costa Rica
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United Kingdom, Finland, Norway, Canada, Mexico, Argentina, Brazil, United States
-
TakedaTerminatedType 2 DiabetesUnited States, Argentina, Mexico, Chile, Peru
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Mannkind CorporationCompletedType 1 Diabetes | Type 2 DiabetesUnited States, Brazil, Canada, Russian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Canada, United Kingdom, Ireland, France, South Africa, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes Mellitus, Type 1Israel, United Kingdom, France, Netherlands, Spain, Finland, Malaysia, Norway, Italy, Germany, Poland, Romania, Portugal, Ireland, Croatia, Greece
-
Hoffmann-La RocheCompletedDiabetesUnited States, Panama, Mexico, Canada, Estonia, Lithuania, Bulgaria, Romania, Latvia, Puerto Rico, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Israel, Poland, United Kingdom, Denmark, Spain, France, Austria, Norway, Russian Federation, Canada, Croatia, Argentina, South Africa, Australia, Ireland, Brazil, Finland
-
Eli Lilly and CompanyInsulet CorporationCompletedType 2 Diabetes MellitusUnited States, Puerto Rico
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Czech Republic, Russian Federation, Ukraine
-
Intarcia TherapeuticsCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Canada, Mexico, Philippines, Romania, Russian Federation, Ukraine
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Israel, Italy, Poland, Russian Federation, United Kingdom, Canada, Denmark, Sweden, Austria, Belgium, Spain, Ireland, Norway, Serbia, Finland, Portugal, Ukraine
-
Novo Nordisk A/SCompletedComparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusCanada, United States, Italy, Poland, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Puerto Rico, Denmark, Sweden, Austria, Germany, Macedonia, The Former Yugoslav Republic of, Slovenia, France, Switzerland, Norway, Spain, Ireland, Finland, Romania
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Italy, Russian Federation, Slovakia, Spain, Ireland, Germany, Turkey, Bulgaria, Hong Kong, Romania, South Africa
-
Eli Lilly and CompanyRecruitingDiabetes Mellitus, Type 2United States, Canada, Mexico, Argentina, Puerto Rico
-
Eli Lilly and CompanyActive, not recruitingDiabetes | Type 1 DiabetesUnited States, Taiwan, Poland, Argentina, Japan, Slovakia, Puerto Rico
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Romania, Canada, Russian Federation, Czech Republic, Slovakia, Mexico
-
XOMA (US) LLCCompletedType 2 Diabetes MellitusUnited States
-
Mannkind CorporationJaeb Center for Health ResearchActive, not recruitingDiabetes Mellitus, Type 1United States
-
Lexicon PharmaceuticalsSanofiTerminatedHeart Failure | Type 2 Diabetes MellitusBelgium, Canada, Israel, Spain, Germany, Argentina, Chile, Hungary, Korea, Republic of, Latvia, Lithuania, Russian Federation, Sweden, Romania, Poland, Brazil, Denmark, United States, Australia, Austria, Czechia, Finland, France, Greece, Ita... and more
-
AstraZenecaCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Puerto Rico
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States
-
SanofiCompletedDiabetes Mellitus, Type 2Brazil, United States, Finland, Spain, Austria, Canada, Czech Republic, France, Greece, Ireland, Israel, Mexico, Netherlands, Russian Federation, Slovakia, Sweden, Turkey
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Israel, South Africa, India, Hungary, Ukraine, Canada, Czech Republic, Mexico, Poland
-
SanofiCompletedDiabetes Mellitus Type 2United States, Austria, Canada, France, Germany, Greece, Guatemala, India, Mexico, Peru, Puerto Rico, Romania, Turkey
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Bulgaria, Denmark, France, Germany, Hong Kong, Hungary, India, Ireland, Italy, Netherlands, Norway, Poland, South Africa, Sweden, United Kingdom
-
Bristol-Myers SquibbMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, Peru, Taiwan, Australia, Philippines, Thailand, Brazil, Chile, India, Russian Federation, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico, Argentina, Thailand, India, Korea, Republic of
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusItaly, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico, Spain, Denmark, Austria, Belgium, Serbia, Germany, Slovenia, Canada, France, Finland, Former Serbia and Montenegro, Czech Republic, Norway
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic ControlUnited States, Canada, Czechia, Germany, Russian Federation, Mexico
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, Finland, Belgium, Hungary, United Kingdom, Germany, Canada, Czechia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Italy, Mexico, Russian Federation, Slovakia, Spain, Canada, Taiwan, Finland, Hungary, Malaysia, South Africa, United Kingdom, Germany, Australia, Thailand, Ireland, Puerto Rico, Singapore
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Slovakia, Japan, Puerto Rico, Serbia, Germany
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Mexico, Israel, Taiwan, Malaysia, Hungary, Turkey, Morocco, Germany, South Africa, Portugal, Lebanon, Italy, Brazil, Croatia, Egypt, Spain, Russian Federation, Greece, Argentina, Korea, Republic of, Poland, Serbia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
PhenomixTerminatedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, India
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Canada, Czechia, Denmark, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Taiwan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Puerto Rico, United Kingdom, Ireland, Germany, Slovenia, Canada, France, Italy, Spain, Netherlands, Slovakia, Romania, Former Serbia and Montenegro
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSlovakia, India, Italy, Russian Federation, Spain, Denmark, United Kingdom, Sweden, Belgium, Ireland, Argentina, Hungary, Norway, South Africa, Germany, Croatia, Netherlands, Bulgaria, Australia, Romania